June 2022 FDA Recall Divalproex Sodium by Sun Pharmaceutical Industries Inc
D-1291-2022 - Failed Dissolution Specifications

This Class II drug recall was voluntarily initiated by Sun Pharmaceutical Industries Inc on June 27, 2022 for the product Divalproex Sodium. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1291-2022

Reason for Recall
Failed Dissolution Specifications: Failure occurred during routine stability testing of dissolution test.
Initiated
06-27-2022
Reported
08-03-2022
Quantity
9552 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
SUN PHARMACEUTICAL INDUSTRIES INC
Nationwide in the USA
Divalproex Sodium Delayed-Release Tablets, USP 500mg, Rx Only, 100 Tablets, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries, Ltd., Halol-Baroda Highway, Halol- 389 350, Gujarat, India, NDC 62756-798-88.

Batch or Lot Expiration Information

Lot# Lot: HAC1312A, EXP. 05/2024